Factors Considered When Choosing a Treatment Plan

Jonathon B. Cohen, MD, MS, elucidates the systematic rationale behind determining the appropriate, incipient treatment for patients with HL and contemplates the safety-to-efficacy ratio when determining options.
For more resources and information regarding anticancer targeted therapies: targetedonc.com/